|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.260 EUR | +3.40% |
|
+2.40% | +15.14% |
| 05-04 | MEDICLIN Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 05-04 | MEDICLIN Aktiengesellschaft Revises Earnings Guidance for the Year 2026 | CI |
| Market Cap | 202M 230M 188M 173M 324M 22.19B 329M 2.23B 873M 10.91B 865M 846M 37.71B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 202M 230M 188M 173M 324M 22.19B 329M 2.23B 873M 10.91B 865M 846M 37.71B | EV / Sales 2026 * |
0.26x | EV / Sales 2027 * | 0.25x |
| Free-Float |
12.27% | Yield 2026 * |
0.94% | Yield 2027 * | 0.94% |
| 1 day | +3.40% | ||
| 1 week | +2.40% | ||
| Current month | +7.58% | ||
| 1 month | +6.50% | ||
| 3 months | +25.29% | ||
| 6 months | +7.04% | ||
| Current year | +15.14% |
| 1 week | 4.08 |  | 4.26 |
| 1 month | 3.9 | | 4.26 |
| Current year | 3.22 | | 4.26 |
| 1 year | 2.86 | | 4.26 |
| 3 years | 2.28 | | 4.26 |
| 5 years | 2.28 | | 4.26 |
| 10 years | 2.28 | | 6.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tino Marco Fritz
CEO | Chief Executive Officer | 49 | - |
Martin Buse
CMP | Compliance Officer | - | - |
Thomas Piefke
COO | Chief Operating Officer | - | 2023-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Hans Hilpert
BRD | Director/Board Member | 60 | 2002-12-31 |
Michael Bock
BRD | Director/Board Member | 63 | 2005-05-24 |
| Director/Board Member | 63 | 2012-09-19 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.40% | +2.40% | +44.90% | +42.00% | 230M | |
| -1.07% | -2.35% | +24.62% | +41.88% | 17.93B | |
| -0.64% | -0.23% | +17.90% | +68.94% | 13.15B | |
| -3.42% | -2.53% | -35.47% | -57.42% | 11.58B | |
| +1.65% | +0.61% | +4.85% | +66.85% | 11.2B | |
| +3.27% | +1.00% | +15.28% | +85.31% | 10.03B | |
| -1.56% | -4.06% | -10.00% | -34.26% | 8.92B | |
| +0.54% | -0.39% | +12.20% | +178.95% | 7.44B | |
| -0.07% | -1.90% | +9.56% | -24.45% | 6.8B | |
| -0.90% | -0.90% | -28.71% | - | 6.69B | |
| Average | +0.12% | -1.06% | +5.51% | +40.87% | 9.4B | |
| Weighted average by Cap. | -0.34% | -1.52% | +3.82% | +39.70% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 787M 897M 732M 672M 1.26B 86.34B 1.28B 8.7B 3.4B 42.45B 3.37B 3.29B 147B | 803M 915M 747M 685M 1.29B 88.07B 1.31B 8.87B 3.47B 43.3B 3.43B 3.36B 150B |
| Net income | 36.66M 41.74M 34.1M 31.29M 58.79M 4.02B 59.69M 405M 158M 1.98B 157M 153M 6.83B | 38.2M 43.49M 35.52M 32.59M 61.24M 4.19B 62.19M 422M 165M 2.06B 163M 160M 7.12B |
| Net Debt | - | - |
Employees
7,416
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-24 | €4.260 | +3.40% | 12,364 |
| 26-07-23 | €4.120 | +0.49% | 1,029 |
| 26-07-22 | €4.100 | -1.44% | 175 |
| 26-07-21 | €4.160 | +0.48% | 801 |
| 26-07-20 | €4.140 | -0.48% | 27 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.260EUR
Average target price
7.300EUR
Spread / Average Target
+71.36%
Net sales - Rate of surprise
- Stock Market
- Stocks
- MED Stock
Select your edition
All financial news and data tailored to specific country editions
